• 1
    Isaacson P, Chott A, Nakamura S. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: SwerdlowSH, CampoE, HarrisN, et al, eds. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008: 214-217.
  • 2
    Zucca E, Bertoni F, Stathis A, Cavalli F. Marginal zone lymphomas. Hematol Oncol Clin North Am. 2008; 22: 883-901, viii.
  • 3
    Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994; 84: 1361-1392.
  • 4
    Zucca E, Conconi A, Pedrinis E, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood. 2003; 101: 2489-2495.
  • 5
    A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood. 1997; 89: 3909-3918.
  • 6
    Wotherspoon AC. Extragastric MALT lymphoma. Gut. 2002; 51: 148-149.
  • 7
    Thieblemont C, Berger F, Dumontet C, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood. 2000; 95: 802-806.
  • 8
    Raderer M, Wohrer S, Streubel B, et al. Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol. 2006; 24: 3136-3141.
  • 9
    Dabaja BS, Ha CS, Wilder RB, et al. Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer J. 2003; 9: 321-324.
  • 10
    Liao Z, Ha CS, McLaughlin P, et al. Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation: natural history and patterns of disease progression. Int J Radiat Oncol Biol Phys. 2000; 48: 399-403.
  • 11
    Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971; 31: 1860-1861.
  • 12
    [no authors listed]. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993; 329: 987-994.
  • 13
    Mazloom A, Medeiros LJ, McLaughlin PW, et al. Marginal zone lymphoma: factors that affect the final outcome: a study of 275 patients. Cancer. 2010; 116: 4291-4298.
  • 14
    Canovas A, Alonso JJ, Barreiro G, Aguirre C. Prognostic factors in follicular lymphoma: the importance of beta-2 microglobulin. Tumori. 2010; 96: 117-121.
  • 15
    Gui W, Wang T, Wang J, et al. An improved prognostic parameter for non-Hodgkin's lymphoma based on the combination of three serum tumor markers. Int J Biol Markers. 2008; 23: 207-213.
  • 16
    Duletic-Nacinovic A, Stifter S, Marijic B, et al. Serum IL-6, IL-8, IL-10 and beta2-microglobulin in association with International Prognostic Index in diffuse large B cell lymphoma. Tumori. 2008; 94: 511-517.
  • 17
    Friedberg JW, Mauch PM, Rimsza LM, Fisher RI. Non-Hodgkin's lymphoma. In: DeVitaVT, LawrenceTS, RosenbergSA, DePinhoRA, WeinbergRA, eds. DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2008: 2098-2142.
  • 18
    Thieblemont C, Bastion Y, Berger F, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol. 1997; 15: 1624-1630.
  • 19
    Brandtzaeg P, Farstad IN, Haraldsen G. Regional specialization in the mucosal immune system: primed cells do not always home along the same track. Immunol Today. 1999; 20: 267-277.
  • 20
    Santacroce L, Cagiano R, Del Prete R, et al. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight. Clin Ter. 2008; 159: 457-462.
  • 21
    Zinzani PL, Magagnoli M, Galieni P, et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol. 1999; 17: 1254.
  • 22
    Tsang RW, Gospodarowicz MK, Pintilie M, et al. Stage I and II MALT lymphoma: results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys. 2001; 50: 1258-1264.
  • 23
    Cahill M, Barnes C, Moriarty P, Daly P, Kennedy S. Ocular adnexal lymphoma-comparison of MALT lymphoma with other histological types. Br J Ophthalmol. 1999; 83: 742-747.
  • 24
    Thieblemont C, Berger F, Coiffier B. Mucosa-associated lymphoid tissue lymphomas. Curr Opin Oncol. 1995; 7: 415-420.